According to Aeterna Zentaris's latest financial reports the company's current earnings (TTM) are -$18.01 M. a decrease over its 2022 earnings that were of -$14.76 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$18.01 M | 22.08% |
2022 | -$14.76 M | 75.31% |
2021 | -$8.42 M | -2.33% |
2020 | -$8.62 M | 38.57% |
2019 | -$6.22 M | -163.17% |
2018 | $9.84 M | -142.65% |
2017 | -$23.08 M | -21.72% |
2016 | -$29.48 M | -16.17% |
2015 | -$35.17 M | 6.09% |
2014 | -$33.15 M | -43.99% |
2013 | -$59.18 M | 195.45% |
2012 | -$20.03 M | -19.45% |
2011 | -$24.87 M | |
2008 | -$63.65 M | 83.07% |
2007 | -$34.77 M | -37.55% |
2006 | -$55.68 M | 917.43% |
2005 | -$5.48 M | -140.4% |
2004 | $13.54 M | -222.55% |
2003 | -$11.06 M | -16.16% |
2002 | -$13.19 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -52,510.04% | ๐จ๐ญ Switzerland |
Sanofi SNY | $8.39 B | -46,720.06% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $8.44 B | -46,968.06% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -$61.89 M | 243.63% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $0.34 B | -2,034.30% | ๐บ๐ธ USA |